Oxiranebutanoic acid,3-(9-hydroxy-1,3,5,7-tetradecatetraenyl)-, [2S-[2a,3b(1E,3E,5Z,7E,9R*)]]- (9CI) (94235-42-4)

Identification
Name:	Oxiranebutanoic acid,3-(9-hydroxy-1,3,5,7-tetradecatetraenyl)-, [2S-[2a,3b(1E,3E,5Z,7E,9R*)]]- (9CI)
Synonyms:	15-Hydroxy-LTA4;15-Hydroxyleukotriene A4
CAS:	94235-42-4
Molecular Formula:	C20H30 O4
Molecular Weight:	0
InChI:	InChI=1/C20H30O4/c1-2-3-8-12-17(21)13-9-6-4-5-7-10-14-18-19(24-18)15-11-16-20(22)23/h4-7,9-10,13-14,17-19,21H,2-3,8,11-12,15-16H2,1H3,(H,22,23)/b6-4+,7-5+,13-9+,14-10+/t17-,18-,19-/m0/s1
Molecular Structure:
Properties
Flash Point:	184.9°C
Boiling Point:	535.1°Cat760mmHg
Density:	1.094g/cm³
Refractive index:	1.563
Flash Point:	184.9°C
Safety Data

Other Product

Oxiranebutanoic acid,3-(1,3,5,8,11-tetradecapentaenyl)-, methyl ester, [2S-[2a,3b(1E,3E,5Z,8Z,11Z)]]- (9CI)
Oxiranebutanoic acid, 3-(9-hydroxy-1,3,5,7-tetradecatetraenyl)-
Oxiranebutanoic acid,3-(1E,3E,5Z)-1,3,5-tetradecatrienyl-,(2S,3S)-
Cyclopropanebutanoicacid, 2-(9-hydroxy-1,3,5,7-tetradecatetraenyl)-, [1R-[1a,2b(1E,3E,5Z,7E,9S*)]]- (9CI)
Oxiranebutanoic acid,3-(1E,3E,5Z,8Z,11Z)-1,3,5,8,11-tetradecapentaenyl-, (2S,3S)- (9CI)
Oxiranebutanoic acid,3-(1E,3E,5Z)-1,3,5-tetradecatrienyl-, methyl ester, (2S,3S)- (9CI)
2-Oxiranebutanoic acid,3-(1E,3E,5Z,8Z)-1,3,5,8-tetradecatetraen-1-yl-, methyl ester, (2S,3S)-
2-Oxiranebutanoic acid,3-(1E,3E,5Z,8Z)-1,3,5,8-tetradecatetraen-1-yl-, (2S,3S)-
2-Oxiranebutanoic acid,3-[(1E,3E)-5-oxo-1,3-pentadien-1-yl]-, methyl ester, (2S,3S)-
L-Ribonamide,N-[(1R,3S)-3-[4-[(1E)-3-[(2R,- 3R,5R,7S,8S,9R)-2-[(1S,3S,4S,5R,6R,7E,9Z,- 11E,13E)-14-cyano-3,5-dihydroxy-1- methoxy-4,6,8,9,13-pentamethyl-7,9,11,13- tetradecatetraenyl]-9-hydroxy-4,4,8-trimethyl- 3-(phosphonooxy)-1,6-dioxaspiro[4.5]dec-7- yl]-1-propenyl]-2-oxazolyl]-1-methylbutyl]- 4-deoxy-4-(dimethylamino)-5-O-methyl-
L-Ribonamide,N-[(1R,3S)-3-[4-[(1E)-3-[(2R,- 3R,5R,7S,8S,9R)-2-[(1S,3S,4S,5R,6R,7E,9Z,- 11E,13Z)-14-cyano-3,5-dihydroxy-1- methoxy-4,6,8,9,13-pentamethyl-7,9,11,13- tetradecatetraenyl]-9-hydroxy-4,4,8-trimethyl- 3-(phosphonooxy)-1,6-dioxaspiro[4.5]dec-7- yl]-1-propenyl]-2-oxazolyl]-1-methylbutyl]- 4-deoxy-4-(dimethylamino)-5-O-methyl-
2-Oxiranebutanoic acid,3-(1E,3E,5Z,8Z)-1,3,5,8-tetradecatetraen-1-yl-, methyl ester, (2R,3R)-rel-
5-Heptenoic acid,7-[3-(2-hydroxy-3,5-undecadienyl)oxiranyl]-, [2R-[2a(Z),3a(2R*,3E,5Z)]]- (9CI)
4,15-Dioxabicyclo[9.3.1]pentadec-7-en-3-one,5-[(1E,3E)-6-[(1R,2S)-2-chlorocyclopropyl]- 1,3-hexadien-5-ynyl]-13-[(6-deoxy-3-Cmethyl- 2-O-methyl-â-D-mannopyranosyl)- oxy]-1-hydroxy-9-methoxy-7,10,12- trimethyl-,(1S,5R,7E,9R,10R,11R,12R,13S)- rel-
4,15-Dioxabicyclo[9.3.1]pentadec-7-en-3-one,5-[(1E,3E)-6-[(1R,2S)-2-chlorocyclopropyl]- 1,3-hexadien-5-ynyl]-13-[[4,6-dideoxy-4- (formylamino)-3-C-methyl-2-O-methyl-â- D-talopyranosyl]oxy]-1-hydroxy-9-methoxy- 7,10,12-trimethyl-,(1S,5R,7E,9R,10R,11R,12R,- 13S)-rel-
9,10-Secocholesta-5,7,10(19)-trien-3-ol,2-fluoro-, (2a,3b,5Z,7E)- (9CI)
L-Ribonamide,N-[(3S)-3-[4-[(1E)-3-[(2R,3R,- 5R,7S,8S,9R)-2-[(1S,3S,4S)-4-[(2S,3S,4R,5S)- 4-bromo-5-[(1E,3E,5Z)-6-cyano-1,5- dimethyl-1,3,5-hexatrienyl]tetrahydro-3,5- dimethyl-2-furanyl]-3-hydroxy-1-methoxypentyl]- 9-hydroxy-4,4,8-trimethyl-3- (phosphonooxy)-1,6-dioxaspiro[4.5]dec-7-yl]- 1-propenyl]-2-oxazolyl]butyl]-4-deoxy-4- (dimethylamino)-5-O-methyl-
9-Undecenoic acid,11-hydroxy-11-(3-pentyloxiranyl)-, methyl ester, [2S-[2a(9Z,11R*),3b]]- (9CI)
b-D-Glucopyranosiduronic acid, (1a,3b,5Z,7E)-1-hydroxy-9,10-secocholesta-5,7,10(19)-trien-3-yl(9CI)
2,4,6-Heptatrienoicacid,7-[tetrahydro-3-hydroxy-5-[2-methoxy-1,3-dimethyl-7-[[1-oxo-2-[tetrahydro-2,3,4-trihydroxy-5,5-dimethyl-6-(1,3-pentadienyl)-2H-pyran-2-yl]butyl]amino]-3,5-heptadienyl]-2-furanyl]-,[2R-[2a,2[S*[1S*[2R*(2E,4E,6E),3R*,5R*],2S*,3E,5E]],3b,4b,6b(1E,3Z)]]- (9CI)